Results are reviewed before the prescription is transmitted to the pharmacy
As the second major human incretin, activated GIP receptors significantly improve systemic insulin sensitivity, reverse severe insulin resistance, and specifically reduce abnormal fat deposition in the liver, abdomen, and blood vessels, improving metabolic disorders and visceral obesity

Meal Timing and Composition A 2021 multidisciplinary expert consensus published in Postgraduate Medicine (Taylor et al.) recommends for GLP-1 agonist GI management: Smaller, more frequent meals 3-4 smaller meals spaced 3-4 hours apart reduces the gastric load at any given time Reduce dietary fat high-fat meals slow gastric emptying further, compounding the delay caused by GLP-1 activation Avoid spicy foods capsaicin and other irritants exacerbate GI inflammation in the context of slowed motility Prioritize soft, easy-to-digest foods soups, yogurt, and well-cooked vegetables reduce mechanical stress on the stomach Hydration Adequate fluid intake supports gastric motility and reduces constipation one of the secondary causes of abdominal pain on retatrutide

High-purity, research-grade peptide synthesis Analytical testing to verify quality and composition Consistent batch-to-batch performance Batch identification on every vial for traceability Stored and shipped under controlled conditions Melanocortin receptor agonist promoting melanogenesis and skin tanning without UV exposure